Non-Sponsored Symposium (NSS)

Transgender therapy and relationship with bone disorders
Chairperson: Bruno Muzzi Camargos
Guidelines for hormonal therapy on transgender patients - Ariana Sierra Osorio
From man to woman and from woman to man: Does it matter? - Andres Coy
Densitometric acquisition, analysis and reporting - Bruno Muzzi Camargos
Recommendations to maintain bone health on transgender patients - Adriana Medina Orjuella

Vitamin D deficiency and rheumatic diseases
Chairperson: Panagiotis Athanassiou
Vitamin D deficiency and autoimmunity - Ifigenia Kostoglou‑Athanassiou
Vitamin D deficiency and rheumatoid arthritis - Yannis Dionyssiotis
Vitamin D deficiency and systemic lupus erythematosus - Panagiotis Athanassiou
Vitamin D receptor polymorphisms and autoimmune diseases - Lambros Athanassiou

Global Impact of Bone Health TeleECHO: The Prototype for Technology Enabled Collaborative Learning for Skeletal Healthcare
Chairperson: E. Michael Lewiecki
Introduction and Background of Bone Health TeleECHO - E. Michael Lewiecki
National University of Ireland Galway Bone Health TeleECHO - John J. Carey
Bone Health TeleECHO Moscow - Zhanna Belaya
Rare Bone Disease TeleECHO - Kassim Javaid

Artificial Intelligence (AI) in Musculoskeletal Imaging – A Paradigm Shift ‘ante portas’?
Chairperson: Hans Peter Dimai
AI in various modalities of musculoskeletal imaging (radiography, DXA, CT, MRT) - Ronald M. Summers
Knee osteoarthritis assessment by AI increases physicians’ agreement rate and accuracy - Stefan Nehrer

Managing fracture risk in primary care: roles and requirements
Chairperson: Z. Paskins
Current challenges for primary care osteoporosis management - Z. Paskins
What osteoporosis care looks like in current UK general practice - Elizabeth Cottrell
Primary care and the management of special groups at risk of fracture - Elizabeth Cottrell
How primary care osteoporosis management can be improved - John Edwards
Summing up: Challenges and opportunities for better integration of primary and secondary care - Z. Paskins
Close - Z. Paskins

Nationwide identification of vertebral fragility fractures: Collaborating with Radiology
Chairperson: Bo Abrahamsen
Collaboration for better patient outcomes in vertebral fracture - Jill Griffin
National audit on the reporting of incidentally found vertebral fractures in routine radiology practice - Nadia Mahmood
Evaluation of the identification of vertebral fractures within fracture liaison services- looking to the future - Kassim Javaid
Evaluating the demand on fracture liaison services with effective identification of vertebral fractures - Helen Glenn

Winning the political case for change – launch of a policy toolkit for osteoporosis and fragility fractures
Chairperson: Ed Harding
Welcome and introduction - Ed Harding
What we know: critical challenges in osteoporosis and fragility fracture care - Cyrus Cooper
The way forward: political actions needed to improve prevention and care of osteoporosis and fragility fractures - John Bowis
Next steps for the network - Jody Tate
Discussion - With Ed Harding, Cyrus Cooper and John Bowis, moderated by Jody Tate
Concluding remarks - Jody Tate

Targeting bone and muscle: Novel therapeutic approaches to osteosarcopenia
Chairperson: Serge Ferrari
RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass from mice to humans - Nicolas Bonnet
Old and new roles of amino acids and amino butyric acids in musculoskeletal diseases - Marco Brotto
Fat as a therapeutic target in osteosarcopenia - Gustavo Duque

Joint Symposium of the IOF Skeletal Rare Diseases Working Group (SRD-WG) and the a European Reference Network on Rare Bone Diseases (ERN-BOND)
Chairperson: Maria Luisa Brandi
Diversity on the pathophysiology of increased bone fragility in rare bone diseases - Naveen Hamdy
Quality of bone in Osteogenesis Imperfecta patients - Luca Sangiorgi

The importance of explanations: improving communication about osteoporosis and osteoarthritis to support uptake of evidence-based treatments
Chairperson: John Edwards
Evidence-care gap in osteoporosis and osteoarthritis - John Edwards
What do we already know about how to frame explanations? - Z. Paskins
Targeting communication in the clinician-patient consultation to improve uptake of fracture prevention treatments: early findings from the iFraP study - Z. Paskins
What patients with osteoarthritis want and need to know to support them to undertake self-management: early findings from the PEP-OA study - Elizabeth Cottrell
Lessons for clinical practice and research - John Edwards
Close - John Edwards

CTF getting to gold framework
Chairperson: Kassim Javaid
Presentation of the Getting to Gold programme framework and milestones - Kassim Javaid
Evaluation of the mentorship programme - Monica Calo
Evaluation of the mentorship programme- mentees perspective - Andrea Olascoaga
Next steps for Getting to Gold - Kassim Javaid

Stronger Together: Innovative Collaborative Initiatives to Improve Osteoporosis Care The Asia Pacific Consortium on Osteoporosis and the Asia Pacific Fragility Fracture Alliance
Chairperson: John A. Kanis
The Burden of Osteoporosis and Fragility Fractures in Asia Pacific - Joon‑Kiong Lee
Asia Pacific Consortium on Osteoporosis: Development of The Framework - Manju Chandran
Asia Pacific Fragility Fracture Alliance: Working group outputs - Derrick Chan
Q&A Session

Inter-relation between bone, muscle, strength and fat in older adults: influence of nutrition and exercise
Chairperson: Mylène Aubertin‑Leheudre
Influence of initial protein intake on bone density and architecture in dynapenic-obese older adults - Fanny Buckinx
Preserving Body & muscle composition in Obese-Osteopenic Older Women: High-Intensity Interval Training a potential intervention? - Mylène Aubertin‑Leheudre
Physical performance in obese-osteopenic elderly women: high-intensity interval training more efficient than continuous aerobic training? - Bertrand Fougère

Bone Health in Patients with Chronic Kidney Disease
Chairperson: Matthew Abramowitz
Bone disorders, mineral metabolism, and vascular calcification in chronic kidney disease - Wei Chen
Bone disease, muscle dysfunction, and sarcopenia in chronic kidney disease - Matthew Abramowitz

Patient-reported outcomes in sarcopenia
Chairperson: Yves Rolland, Olivier Bruyère
Welcome and introduction - Olivier Bruyère
Quality of life in sarcopenia : an update - Charlotte Beaudart
Overview of generic and specific Patient Reported Outcome Measures (PROMs) in sarcopenia - Anton Geerinck
Conclusion - Yves Rolland

DENOSUMAB discontinuation: Trends, challenges, ups-and-downs
Chairperson: Bruno Muzzi Camargos
Vertebral Fracture Following D-Mab Discontinuation: Supporting Data - Oscar Rosero Olarte
Pathophysiology Of The Osteoclastic “Flare” After Discontinuation Adriana - Medina Orjuella
Biochemichal And Imaging Assessment: Ups And Downs - Bruno Muzzi Camargos
Bone Loss After D-Mab Discontinuation In 150 Patients - Maria Belen Zanchetta
D-Mab Patient Management In The Clinical Setting: Stepping On The Right Foot - Luis Fernando Vidal Neira

When a DXA is indicated, a VFA is also recommended
Chairperson: Willem Lems, Kristina Åkesson
Introduction - Willem Lems
Clinical relevance of vertebral fractures - Julien Paccou
Radiological diagnosis of vertebral fractures with VFA - Jean Zhang
Advantages and limitations of VFA - Manju Chandran
Conclusion - Kristina Åkesson

Fragility fractures in Sub-Saharan Africa: Time to break the myth!
Chairperson: Celia Gregson
Chairs introduction and setting the scene - Kate Ward
Trends in fracture incidence in high-income countries - Bo Abrahamsen
Breaking the myth in Sub-Saharan Africa – what do we know about fragility fracture? - Kate Ward
Summary and wrap-up - Kate Ward

Female Bone Health: a gynecological approach on women's special conditions
Chairperson: Adriana Orcesi Pedro
Opening - Adriana Orcesi Pedro
Update on management of low bone mass in young women - Adriana Orcesi Pedro
Bone mass and fracture risk during pregnancy and lactation - Ben‑Hur Albergaria
Evaluation and management of osteopenia and osteoporosis in breast and gynecological cancer survivors - Marcelo Luis Steiner

Sarcopenic obesity
Chairperson: Ifigenia Kostoglou‑Athanassiou
Sarcopenia. Diagnosis and evaluation - Panagiotis Athanassiou
Sarcopenia and nutrition - Lambros Athanassiou
Sarcopenic obesity. Definition and pathophysiology - Ifigenia Kostoglou‑Athanassiou
Sarcopenic obesity. Management - Yannis Dionyssiottis

The Brussels study on the early predictors of frailty (BUTTERFLY) – part 1: Defining Frailty
Chairperson: Dominique Verté
Introduction - Ivan Bautmans
Towards a uniform language of Frailty - Roberta Vella‑Azzopardi
Fatigue in the frailty constructs - Veerle Knoop
The disability paradox in the frailty constructs - Axelle Costenoble
Measures of cognition in the frailty constructs - Ellen Gorus

The Brussels study on the early predictors of frailty (BUTTERFLY) – part 2: First results from the BUTTERFLY study
Chairperson: Dominique Verté
Introduction - Ivan Bautmans
General profile of the Butterfly participants - Aziz Debain
Validated equations for estimating body composition in the oldest old - Jona Van den Broeck
Immunosenescence signatures in pre-frailty - Rose Njemini

Clinical diagnostics of chronic and acute pain. Multimodal approach
Chairperson: Olga Kurushina
Acute and chronic pain: The difference between diagnostic approaches - Olga Kurushina
Pain and biomechanics - Alexander Barulin
Features of clinical diagnosis of cervicogenic headache - Anna Drushlyakova
Diagnosis of temporomandibular disorders in patients with chronic facial pain - Bogdan Kalinchenko

Awareness, Risk factors and Early Detection of Osteoporosis in Turkish Postmenopausal Female Patients
Chairperson: Pinar Borman, Vesile Sepici
The Awareness and Knowledge of Osteoporosis and Risk factors in a group Turkish Geriatric Patients - Belgin Karaoglan
The Knowledge about Osteoporosis in a Group of Turkish Females: Relationship with Quantitative Ultrasonographic Scores - Pinar Borman
Laboratory overview of bone turnover markers - Aylin Sepici Dincel
Risk Factors of osteoporosis and osteoporotic fractures - Vesile Sepici

Controversies regarding the management of gout and asymptomatic hyperuricemia
Chairperson: Razvan Adrian Ionescu
Uric acid - Friend or foe? - Mihai Bojinca
Asymptomatic hyperuricemia - The hidden realm (Imaging clue) - Florentin Ananu Vreju
Bone mineral density in hyperuricemia and gout - Collateral damage? - Claudiu Avram
Gout treatment - As easy as it seems? - Razvan Adrian Ionescu

The microcirculation abnormalities in osteoporosis and osteoarthritis
Chairperson: Sekib Sokolovic, Alena Rudenko
Introduction - Sekib Sokolovic
Angiogenesis and Bone - Gerold Holzer
Vascular pathology and Osteoarthritis, Imaging of Microcirculation - Juan Jose Scali
The Microcirculation abnormalities in Osteoporosis and Osteoarthritis - Sekib Sokolovic

Non-pharmacological approaches in the management of osteoporosis
Chairperson: Yesim Gokce Kutsal
How to modify life-style? - Yesim Gokce Kutsal
The role of exercises: What type of exercise when? - Jale Meray
Are orthoses and physical modalities effective for osteoporosis and/or osteoporotic fractures? - Ayse A. Kucukdeveci
Case presentations - Yesim Kirazli

Relevance of body composition in chronic diseases
Chairperson: Mislav Radić
Association of body composition with disease activity in rheumatoid arthritis - Mislav Radić
Relationship of body composition with osteoporosis - Tonko Vlak
Impact of disability on body composition in multiple sclerosis - Ozren Polasek

Osteosarcopenia school
Chairperson: Mark Lissens, Yannis Dionyssiotis
Osteosarcopenia - Ifigenia Kostoglou‑Athanassiou
Neurogenic osteoporosis due to sarcopenia in post poliomyelitis patients - Mark Lissens
Osteosarcopenia school - Yannis Dionyssiotis